Melissa Stanton

39.1k total citations
48 papers, 877 citations indexed

About

Melissa Stanton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Melissa Stanton has authored 48 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Melissa Stanton's work include Renal cell carcinoma treatment (21 papers), Renal and related cancers (13 papers) and Cancer Genomics and Diagnostics (12 papers). Melissa Stanton is often cited by papers focused on Renal cell carcinoma treatment (21 papers), Renal and related cancers (13 papers) and Cancer Genomics and Diagnostics (12 papers). Melissa Stanton collaborates with scholars based in United States, Czechia and India. Melissa Stanton's co-authors include Thai H. Ho, Erik P. Castle, Richard W. Joseph, Toni K. Choueiri, Sabina Signoretti, Michael B. Atkins, André P. Fay, David F. McDermott, Joaquim Bellmunt and Laurence Albigès and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Melissa Stanton

44 papers receiving 865 citations

Peers

Melissa Stanton
Melissa Stanton
Citations per year, relative to Melissa Stanton Melissa Stanton (= 1×) peers Hongdian Zhang

Countries citing papers authored by Melissa Stanton

Since Specialization
Citations

This map shows the geographic impact of Melissa Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Stanton more than expected).

Fields of papers citing papers by Melissa Stanton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Stanton. The network helps show where Melissa Stanton may publish in the future.

Co-authorship network of co-authors of Melissa Stanton

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Stanton. A scholar is included among the top collaborators of Melissa Stanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Stanton. Melissa Stanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Sounak, Surendra Dasari, Wei Shen, et al.. (2025). Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT. Human Pathology. 160. 105813–105813. 4 indexed citations
2.
Shah, Anoop, Irbaz Bin Riaz, Kevin D. Courtney, et al.. (2024). The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate. Clinical Genitourinary Cancer. 22(5). 102172–102172. 1 indexed citations
3.
Stanton, Melissa, et al.. (2023). Imaging and pathologic correlation of composite pheochromocytoma-ganglioneuroma. Japanese Journal of Clinical Oncology. 53(5). 452–453.
4.
Gupta, Sounak, Melissa Stanton, Jordan Reynolds, et al.. (2023). Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma. Human Pathology. 133. 136–152. 3 indexed citations
5.
Khoury, Louis Y. El, Xiaoyu Pan, Ryan A. Hlady, et al.. (2023). Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. Clinical Epigenetics. 15(1). 71–71. 6 indexed citations
6.
Hoegger, Mark J., David H. Ballard, Cary Siegel, et al.. (2022). Urinary Bladder Masses, Rare Subtypes, and Masslike Lesions: Radiologic-Pathologic Correlation. Radiographics. 43(1). 27–28. 16 indexed citations
7.
Gupta, Sounak, Melissa Stanton, Jordan Reynolds, et al.. (2022). Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Human Pathology. 129. 123–139. 7 indexed citations
8.
Gupta, Sounak, Andrew L. Folpe, Jorge Torres‐Mora, et al.. (2022). Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Human Pathology. 128. 110–123. 11 indexed citations
9.
Nevo, Amihay, Eli Muchtar, Karen Stern, et al.. (2020). The Clinical Implication of Incidental Prostatic Amyloidosis. Urology. 145. 253–257. 4 indexed citations
10.
Wilson, Mike R., Galen Hostetter, Bree D. Berghuis, et al.. (2020). Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta. Stem Cell Research. 46. 101849–101849. 2 indexed citations
11.
Barrett, Michael T., Melissa Stanton, James L. Slack, et al.. (2019). Clonal analyses of refractory testicular germ cell tumors. PLoS ONE. 14(3). e0213815–e0213815. 16 indexed citations
12.
Ferdosi, Shadi, Thai H. Ho, Erik P. Castle, Melissa Stanton, & Chad R. Borges. (2018). Behavior of blood plasma glycan features in bladder cancer. PLoS ONE. 13(7). e0201208–e0201208. 16 indexed citations
13.
Ho, Thai H., Jeffrey Swensen, Anatole Ghazalpour, et al.. (2016). Comprehensive profiling of renal medullary and collecting duct carcinomas.. Journal of Clinical Oncology. 34(2_suppl). 572–572. 3 indexed citations
14.
Joseph, Richard W., Sherri Z. Millis, Estrella M. Carballido, et al.. (2015). PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation. Cancer Immunology Research. 3(12). 1303–1307. 131 indexed citations
15.
Ho, Thai H., Huihuang Yan, Jin G. Park, et al.. (2015). A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona. PLoS ONE. 10(7). e0132831–e0132831. 7 indexed citations
16.
Choueiri, Toni K., André P. Fay, Kathryn P. Gray, et al.. (2014). PD-L1 expression in nonclear-cell renal cell carcinoma. Annals of Oncology. 25(11). 2178–2184. 242 indexed citations
17.
Stanton, Melissa, et al.. (2014). Xp11.2 translocation tumor. JAAPA. 27(2). 24–27. 4 indexed citations
18.
Hakim, Fayaz A., Sukhjeet Singh, Anil Pandit, et al.. (2014). Interferon-α and pericardial injury: a case report and literature review. Heart Asia. 6(1). 48–53.
19.
Stanton, Melissa, et al.. (2012). Metastatic Malignant Melanoma to the Bladder: A Case Series. Current Urology. 6(1). 53–56. 3 indexed citations
20.
Si, Qiusheng, Jane Dancer, Melissa Stanton, et al.. (2011). Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Human Pathology. 42(11). 1792–1798. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026